NYSE · MCKConsumer DiscretionaryWholesale Trade

McKesson Corporation (MCK)

$1,093.96+2.29%
Close Nov 5, 2026 · split-adjusted
Nov 5, 2026$1093.96▲ 29.97% in range
Nov 4, 2025Low $725.17 · High $1093.96Nov 5, 2026
What changed · written from our data
As of Nov 5, 2026

McKesson closed at $1,093.96 on Nov 5, up 2.29% — matching its 52-week closing high. Volume of 729.4K shares was 1.03× its 20-day average (close to normal).

Split-adjusted performance: +20.2% over one month, +44.9% over six months, +30.0% over one year.

In the quarter ended Jun 30, 2026, revenue was $105.38B, up 7.7% from a year earlier, with a net margin of 0.6%.

Short interest was 2.3M shares at the Oct 15 settlement (2.0% of float, 3.1 days to cover).

Market cap$127.55B116.6M shares
Revenue · quarter$105.38B+7.7% YoY
Diluted EPS$5.15−17.6% YoY
P/E · TTM27.8×P/S 0.3×
Net margin0.6%Gross 3.5%
Dividend yield0.34%$0.94 last paid
52-week range725.17 – 1093.960.0% from high
Volume729.4K1.03× 20-day avg
Volatility · 60d28.6%Annualised
Short % of float2.0%3.1 days to cover
Net cash-$4.57BCash $5.16B
Next earnings—Not scheduled
Split-adjusted performance
1W +11.5%1M +20.2%3M +25.8%6M +44.9%YTD +33.4%1Y +30.0%3Y +140.2%5Y +433.6%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Wholesale Trade

Percentile among 87 companies (100 = best)

6-month momentum92
Revenue growth55
Net margin34
Value (low P/E)33
Size100

Industry medians: 6-month return −6.5%, revenue growth +6.9%, net margin 1.7%, P/E 20.0×.

Short interest

Details →
Shares short2.3M+0.5% vs prior
Days to cover3.1Settled Oct 15
% of float2.0%
Short vol. 10d40.8%of daily volume

Closest peers by size in Wholesale Trade

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
MCKMcKesson$1,093.96+2.29%+44.9%+7.7%0.6%27.8$127.55B
GWWW.W. Grainger$1,451.46−2.55%+17.6%+10.3%11.4%36.6$68.36BCompare
CORCencora$342.38−3.28%+33.9%+5.1%0.9%24.9$65.34BCompare
CAHCardinal Health$270.95+3.44%+46.2%+5.8%0.6%36.6$62.74BCompare
TELTE Connectivity$209.76−4.75%−0.1%+13.8%14.5%20.0$60.31BCompare
FERGFerguson Enterprises$235.87−5.09%−4.3%+4.6%7.6%—$45.63BCompare
SYYSysco$75.42−1.98%+3.5%+2.8%2.4%20.6$37.13BCompare
USFDUS Foods Holding$107.04−2.63%+23.2%+4.5%2.6%31.8$23.15BCompare
RSReliance$420.87−4.77%+14.0%+42.8%7.7%19.4$21.44BCompare

Quick answers

What does McKesson do?
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry.
What is MCK's market cap?
$127.55B, based on the Nov 5 close of $1,093.96.
What is MCK's P/E ratio?
27.8× trailing-twelve-month earnings of $4.59B.
Does McKesson pay a dividend?
Yes. The latest regular dividend was $0.94 per share (ex-date Sep 1), an annualised yield of 0.34%.
How much of MCK is sold short?
2.3M shares, 2.0% of float, as of Oct 15, 2026.
What sector is MCK in?
Consumer Discretionary, in the Wholesale Trade industry.

About McKesson

McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

HQ: Irving, TX43,000 employeesListed Aug 3, 1987mckesson.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology